Position in PFE
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$994,504
-$458,158 QoQ
Shares Held
41,300
-20.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#1,329
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 60%
Shared 0%
None 40%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PARADIGM ASSET MANAGEMENT CO LLC holds $12,808,040 across 10 Drug Manufacturers - General names. PFE ranks #6 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
14,900 | $3,784,153 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
16,700 | $2,109,878 | |
| 3 | ABBV |
AbbVie Inc.
|
7,300 | $1,836,972 | |
| 4 | MRK |
Merck & Co., Inc.
|
13,500 | $1,734,750 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
20,400 | $1,175,448 | |
| 6 | PFE |
Pfizer Inc
This page
|
41,300 | $994,504 | |
| 7 | LLY |
ELI LILLY & Co
|
550 | $659,686 | |
| 8 | NVS |
Novartis AG
|
1,800 | $282,096 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $994,504 | 41,300 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $1,452,662 | 51,733 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,288,151 | 51,733 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $1,397,144 | 54,833 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,329,151 | 54,833 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $1,092,990 | 43,133 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $1,144,318 | 43,133 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $1,259,845 | 43,533 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $1,218,053 | 43,533 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,238,565 | 44,633 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,325,290 | 46,033 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,566,718 | 47,233 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $1,820,538 | 49,633 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,812,866 | 44,433 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,284,432 | 44,583 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,161,000 | 49,383 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,610,122 | 49,783 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $2,577,265 | 49,783 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $2,939,686 | 49,783 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,995,664 | 46,400 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,907,092 | 48,700 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $1,764,401 | 48,700 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $1,844,181 | 50,100 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,242,367 | 61,100 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,302,082 | 70,400 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $2,510,012 | 76,900 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||